September 2020 - Global Life Science Business Partnering - News & Updates
Highlights of September 2020
- Serum Institute of India gets further US$150 Million from Bill & Melinda Gates Foundation for additional 100 Million vaccines.
- Strides Pharma to Buy 54% Stake In SteriScience For Rs 135 Crore(US$ 18.4 Million).
- Aurobindo Pharma ties up with BIRAC to develop Covid-19 vaccine.
- Saptagir Laboratories signs Remdesivir manufacturing deal with Jubilant Generics.
- Bharat Biotech inks deal with Washington University School of Medicine for COVID-19 intranasal vaccine.
- IICT partners with Mylan to identify COVID-19 therapies.
- Smith & Nephew to pick up Integra's orthopedics business for US$240 Million.
- Bausch inks US$50 Million option to grab Allegro's eye disease pipeline.
- Novartis, Siemens to develop blood tests for multiple sclerosis.
- Medtronic to acquire Avenu Medical and its outpatient procedure for creating dialysis fistulas.
- Jazz Pharma partners with Durbin on global EAP for narcolepsy drug.
- Vifor Pharma sells OM Pharma to Optimus.
- BioNTech buys Novartis plant for COVID-19 vaccine, eyes capacity of up to 750 Million doses.
- ARS Pharma and Recordati agree deal for epinephrine auto-injector.
Highlights at Aagami:
- New Assignment from Existing Client: Our client, a clinical stage French Pharma developing a smoking cessation drug extracted from natural tobacco leaf , has given us fresh mandate for supporting their investment and partnering needs, also.
- New Client Win: Aagami has been appointed by a Portugal headquartered pharmaceutical company. As per the scope of the assignment, Aagami and its partners shall provide consultation in the form of a report describing the most appropriate regulatory pathway to obtain India marketing authorization for client’s asset, a topical minocycline.
- Aagami to attend Digital BIO-Europe® 2020 (October 26–29, 2020).